Obtaining prefrontal cortex biopsies during deep brain stimulation (DBS) surgery in living patients does not increase the risk of adverse events or cognitive decline compared to standard DBS ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

Prefrontal cortex biopsies taken for research purposes during deep brain stimulation (DBS) procedures appeared to be safe, new research has suggested. Investigators found no significant differences in ...

A traditionally overlooked type of RNA plays an important role in promoting resilience to depression-but only in females. According to a new study led by the Icahn School of Medicine at Mount Sinai, ...

The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe ...

WASHINGTON — The government has approved the first non-invasive brain stimulator to treat depression — a device that beams magnetic pulses through the skull. If it sounds like science-fiction, well, ...

Researchers have reported finding major differences between postmortem and living prefrontal cortex brain tissues as they relate to one of the most abundant RNA modifications in the brain, known as ...

Attention depends on the brain’s ability to filter out distractions, but new research suggests this works best when ...